GeneHealth - Your precision medicine

Job's Syndrome

Disease Details

Family Health Simplified

Buy Membership

Description: Job's syndrome, also known as Hyper-IgE Syndrome (HIES), is a rare immunodeficiency disorder characterized by high levels of immunoglobulin E (IgE), recurrent skin abscesses, pneumonia, and skeletal abnormalities.
Type: Job's Syndrome, also known as Hyper-IgE Syndrome (HIES), is primarily an immunodeficiency disorder. The genetic transmission can be either autosomal dominant or autosomal recessive, with the autosomal dominant form being more common and typically caused by mutations in the STAT3 gene.
Signs And Symptoms: Job's Syndrome, also known as Hyper IgE Syndrome, is a rare immunodeficiency disorder. Here are the signs and symptoms:

- Recurrent skin abscesses
- Eczema
- Severe lung infections
- High levels of immunoglobulin E (IgE)
- Facial features like deep-set eyes, broad nose, and rough skin
- Retained primary teeth

Please specify what "nan" refers to so I can provide accurate information based on your query.
Prognosis: Job's Syndrome, also known as Hyper-IgE Syndrome (HIES), can vary in its prognosis depending on the severity of the condition and the effectiveness of management strategies. Generally, individuals with Job's Syndrome require lifelong monitoring and treatment to manage recurrent infections and associated complications. With appropriate medical care, including antibiotics for infections and other supportive therapies, many patients can lead relatively normal lives. However, the condition can be serious, and severe cases may impact life expectancy and quality of life due to complications such as lung infections or other organ involvement. Regular follow-up with healthcare providers specializing in immunodeficiency disorders is crucial for optimizing outcomes.
Onset: Job's Syndrome, also known as Hyper IgE Syndrome (HIES), typically has an onset in early childhood. Signs and symptoms often appear in the first few months of life.
Prevalence: Job's Syndrome, also known as Hyper-IgE Syndrome (HIES), is a rare primary immunodeficiency disorder. The prevalence of this condition is estimated to be around 1 in 1,000,000 individuals.
Epidemiology: Job's Syndrome, also known as Hyper-IgE Syndrome (HIES), is a rare primary immunodeficiency disorder. The exact prevalence is not well established due to its rarity. It is estimated to affect about 1 in 1 million people. It can occur in both males and females and is typically diagnosed in childhood. The syndrome can be caused by mutations in the STAT3 gene or other genes involved in the immune system. Different forms of the syndrome can be inherited in an autosomal dominant or autosomal recessive manner.
Intractability: Job's syndrome, also known as Hyper-IgE Syndrome (HIES), can be challenging to manage but is not necessarily intractable. Treatment typically involves managing infections with antibiotics and antifungals, maintaining good skin care, and sometimes using immunomodulatory therapies. While there is no cure, these measures can significantly improve quality of life and reduce complications.
Disease Severity: Job's syndrome, also known as Hyper-IgE Syndrome (HIES), is a primary immunodeficiency disorder characterized by elevated levels of immunoglobulin E (IgE) and recurrent infections. The severity of the disease can vary significantly between individuals, ranging from mild to severe. In severe cases, patients may experience frequent, severe infections, chronic lung disease, skin abscesses, and other complications that can significantly impact their quality of life. Early diagnosis and appropriate medical management are crucial in mitigating the severity of the disease.
Healthcare Professionals: Disease Ontology ID - DOID:3261
Pathophysiology: Abnormal neutrophil chemotaxis due to decreased production of interferon gamma by T lymphocytes is thought to cause the disease.Both autosomal dominant and recessive inheritance have been described:Autosomal dominant:

STAT3 may present as HIES with characteristic facial, dental, and skeletal abnormalities that has been called Job's Syndrome. A common mnemonic used to remember the symptoms is FATED: coarse or leonine facies, cold staph abscesses, retained primary teeth, increased IgE, and dermatologic problems [eczema]. The disease was linked to mutations in the STAT3 gene after cytokine profiles indicated alterations in the STAT3 pathway. This altered pathway directly reduces the modulation capacity of interleukins 6 and 10 which, respectively, inhibit the genesis of Th17 cells that, in tandem with CD4 cells, protect against bacterial and fungal infections, and foster the inappropriate immune responses exhibited by those with Job Syndrome.Autosomal recessive:

DOCK8
Carrier Status: Job's Syndrome, also known as Hyper-IgE Syndrome (HIES), is typically inherited in an autosomal dominant manner but can also occur in an autosomal recessive form. Carrier status, therefore, depends on the specific genetic form:

1. **Autosomal Dominant HIES**: Individuals who inherit a single copy of the mutated gene (from either parent) typically manifest the disorder. Carriers are usually affected since only one mutated copy is needed for the syndrome to present.

2. **Autosomal Recessive HIES**: Two copies of the mutated gene (one from each parent) are required to manifest the disorder. Carriers of the recessive form, having only one mutated copy, typically do not show symptoms and are considered carriers.

Each form of HIES involves different mutations and has different inheritance patterns. The most frequently identified gene mutation for the autosomal dominant form is in the STAT3 gene, while others like DOCK8 and TYK2 are implicated in autosomal recessive forms.
Mechanism: Job's Syndrome, also known as Hyperimmunoglobulin E Syndrome (HIES), is a rare primary immunodeficiency disorder characterized by elevated levels of immunoglobulin E (IgE), eczema, recurrent skin and lung infections, and skeletal abnormalities.

**Mechanism:**
The disorder involves a defect in the immune system, particularly in the processes that regulate inflammation and immune responses. The defective components typically impair the ability of immune cells to respond effectively to infections, leading to increased susceptibility to bacterial and fungal infections.

**Molecular Mechanisms:**
1. **STAT3 Mutation:**
The most common form of Job's Syndrome is caused by mutations in the STAT3 (Signal Transducer and Activator of Transcription 3) gene. STAT3 is crucial for the signaling pathways that mediate the immune response and the development of Th17 cells, which are essential for defending against fungal and bacterial infections.

2. **Th17 Cell Deficiency:**
Mutations in the STAT3 gene lead to a reduction in Th17 cells, a subset of helper T cells that produce interleukin-17 (IL-17), a cytokine vital for neutrophil recruitment and fungal defense. This deficiency weakens the immune system's ability to fend off infections, particularly those caused by Staphylococcus aureus and Candida albicans.

3. **Elevated IgE Levels:**
The exact reason for elevated IgE levels is not fully understood, but it is believed to be linked to dysregulation of cytokine production and signaling pathways controlled by the mutated STAT3 protein. The imbalance affects the immune system's response and increases susceptibility to allergies and eczema.

Understanding the molecular mechanisms behind Job's Syndrome is crucial for developing targeted therapies and improving management strategies for affected individuals.
Treatment: Most patients with hyper IgE syndrome are treated with long-term antibiotic therapy to prevent staphylococcal infections. Good skin care is also important in patients with hyper IgE syndrome. High-dose intravenous gamma-globulin has also been suggested for the treatment of severe eczema in patients with HIES and atopic dermatitis.
Compassionate Use Treatment: Job's syndrome, also known as Hyper-IgE Syndrome (HIES), is a rare primary immunodeficiency characterized by elevated levels of Immunoglobulin E (IgE) and recurrent bacterial infections. When considering compassionate use, off-label, or experimental treatments for Job's syndrome, the following approaches may be considered:

1. **Compassionate Use Treatments**:
- Exogenous Interleukin-2 (IL-2): Used to boost immune function.
- Granulocyte-macrophage colony-stimulating factor (GM-CSF): Enhances the production of white blood cells to fight infections.

2. **Off-Label Treatments**:
- Intravenous Immunoglobulin (IVIG): Administered to provide passive immunity and reduce infection severity.
- Biologic agents like anti-IL-6 (e.g., tocilizumab): These can modulate immune response, although not specifically approved for Job's syndrome.

3. **Experimental Treatments**:
- Gene Therapy: Experimental approaches to correct the underlying genetic defects causing Job's syndrome.
- Stem Cell Transplantation: A potential curative treatment being explored to replace the defective immune system with a healthy one.

These treatments should be considered carefully and typically involve rigorous monitoring by healthcare professionals specializing in immunology and infectious diseases.
Lifestyle Recommendations: For Job's Syndrome (also known as Hyper-IgE Syndrome), lifestyle recommendations generally include:

1. **Infection Prevention**: Maintain strict hygiene practices, such as frequent hand washing, bathing, and proper wound care to prevent skin infections.

2. **Regular Medical Follow-ups**: Schedule consistent visits with healthcare providers to monitor and manage symptoms and complications.

3. **Skin Care**: Use emollients and moisturizers to keep the skin hydrated and reduce the risk of eczema and skin infections.

4. **Avoidance of Allergens**: Identify and avoid potential allergens or triggers that could worsen symptoms.

5. **Balanced Diet**: Consume a nutritious diet to support the immune system, including plenty of vitamins and minerals.

6. **Exercise**: Engage in regular, moderate exercise to improve overall health and immune function, but avoid activities that could lead to injuries or infections.

7. **Vaccinations**: Follow recommended vaccination schedules with guidance from healthcare providers, as live vaccines might be contraindicated.

8. **Stress Management**: Practice stress-reducing techniques such as meditation, yoga, or hobbies to maintain overall well-being.

Implementing these recommendations can help manage the symptoms and improve the quality of life for individuals with Job's Syndrome.
Medication: Job's Syndrome, also known as Hyper IgE Syndrome, is a rare immunodeficiency disorder. Treatment often includes:

1. Antibiotics: To prevent and treat recurrent bacterial infections. Long-term prophylactic antibiotics may be prescribed.
2. Antifungals: To manage and prevent fungal infections.
3. Immunoglobulin Therapy: Intravenous immunoglobulin (IVIG) may be given to boost the immune system.
4. Anti-inflammatory Medications: To manage inflammation and skin issues.
5. Preventative Skin Care: Regular skin care to prevent infections, along with topical treatments for skin inflammation.

Patients with Job's Syndrome require individualized treatment plans tailored to their specific symptoms and complications. Regular follow-up with a healthcare provider specializing in immunology is essential.
Repurposable Drugs: Job's Syndrome, also known as Hyper-IgE Syndrome (HIES), is a rare immunodeficiency disorder characterized by high levels of immunoglobulin E (IgE), eczema, and recurrent skin and lung infections. Repurposable drugs that have shown potential in managing some aspects of Job’s Syndrome include:

1. **Itraconazole and Voriconazole:** These antifungal agents are used to treat fungal infections, which are common in Job’s Syndrome patients.
2. **Antibiotics (e.g., Trimethoprim-sulfamethoxazole):** Used prophylactically to reduce the frequency of bacterial infections, especially those caused by Staphylococcus aureus.
3. **Biologics (e.g., Interferon-gamma):** Limited studies suggest potential in modulating immune responses although more research is needed.

There is, however, a paucity of research specifically targeting Job’s Syndrome with repurposed drugs, and treatment typically remains symptomatic and supportive.
Metabolites: Job’s syndrome, also known as Hyper-IgE Syndrome (HIES), is a rare primary immunodeficiency disorder. The specific metabolites associated with Job's syndrome are not well-characterized, but metabolic abnormalities may arise due to the underlying immune dysregulation. Generally, patients with Job's syndrome have elevated levels of Immunoglobulin E (IgE). As for "nan," it is not directly related to the discussion of metabolites in Job's syndrome and might be a typographical error or require further context. If you have more specific questions or need details on a related topic, please provide additional information.
Nutraceuticals: Job's Syndrome, also known as Hyper-IgE Syndrome, is a rare primary immunodeficiency disorder characterized by elevated levels of immunoglobulin E (IgE), recurrent skin abscesses, pneumonia, and eczema. Nutraceuticals may offer supportive care but are not a primary treatment. Key considerations include:

1. **Vitamin D:** Supplementing with vitamin D can support the immune system.
2. **Omega-3 Fatty Acids:** Found in fish oil, these have anti-inflammatory properties.
3. **Probiotics:** Can help maintain gut health and potentially support immune function.

However, these supplements should be considered as part of a broader treatment plan under medical supervision. There is currently no nanotechnology-based treatment specifically for Job's Syndrome.
Peptides: Job's syndrome, also known as Hyper IgE Syndrome (HIES), is a rare immunodeficiency disorder. There is not a specific known peptide treatment for Job's syndrome. Treatment typically focuses on managing infections and controlling symptoms. Nanotechnology is being explored in various areas of medicine, including immunodeficiency disorders, but there are no established nanotechnology treatments specifically for Job's syndrome at this time.